{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:00:52Z","timestamp":1791352852738,"version":"4.3.1"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Psychiatry Rep"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s11920-010-0160-4","type":"journal-article","created":{"date-parts":[[2010,10,20]],"date-time":"2010-10-20T09:05:22Z","timestamp":1287565522000},"page":"553-562","source":"Crossref","is-referenced-by-count":120,"title":["Biomarkers to Predict Antidepressant Response"],"prefix":"10.1007","volume":"12","author":[{"given":"Andrew F.","family":"Leuchter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian A.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven P.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L.","family":"Narr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Toga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimee M.","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kym","family":"Faull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Whitelegge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Loo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baldwin","family":"Way","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley F.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Horvath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry D.","family":"Lebowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,10,21]]},"reference":[{"key":"160_CR1","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.4088\/JCP.v64n1211","volume":"64","author":"P Greenberg","year":"2003","unstructured":"Greenberg P, Kessler R, Birnbaum H: The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry 2003, 64:1465\u20131475.","journal-title":"J Clin Psychiatry"},{"key":"160_CR2","doi-asserted-by":"crossref","first-page":"435","DOI":"10.31887\/DCNS.2009.11.4\/afleuchter","volume":"11","author":"AF Leuchter","year":"2009","unstructured":"Leuchter AF, Cook IA, Hunter AM, Korb AS: A new paradigm for the prediction of antidepressant treatment response. Dialogues Clin Neurosci 2009, 11:435\u2013446.","journal-title":"Dialogues Clin Neurosci"},{"key":"160_CR3","volume-title":"Guideline Watch: Practice Guideline for the Treatment of Patients With Major Depressive Disorder","author":"LJ Fochtmann","year":"2005","unstructured":"Fochtmann LJ, Gelenberg AJ: Guideline Watch: Practice Guideline for the Treatment of Patients With Major Depressive Disorder, edn 2. Washington, DC: American Psychiatric Association; 2005.","edition":"2"},{"key":"160_CR4","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1056\/NEJMoa052964","volume":"354","author":"MH Trivedi","year":"2006","unstructured":"Trivedi MH, Fava M, Wisniewski SR, et al.: Medication augmentation after the failure of SSRIs for depression. N Engl J Med 2006, 354:1243\u20131252.","journal-title":"N Engl J Med"},{"key":"160_CR5","first-page":"627","volume":"23","author":"AJ Rush","year":"2009","unstructured":"Rush AJ, Warden D, Wisniewski SR, et al.: STAR*D: revising conventional wisdom. CNS Drugs 2009, 23:627\u2013647.","journal-title":"CNS Drugs"},{"issue":"Suppl 10","key":"160_CR6","first-page":"8","volume":"68","author":"AJ Rush","year":"2007","unstructured":"Rush AJ: Limitations in efficacy of antidepressant monotherapy. J Clin Psychiatry 2007, 68(Suppl 10):8\u201310.","journal-title":"J Clin Psychiatry"},{"key":"160_CR7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1176\/ajp.149.8.1128","volume":"149","author":"GI Keitner","year":"1992","unstructured":"Keitner GI, Ryan CE, Miller IW, Norman WH: Recovery and major depression: factors associated with twelve-month outcome. Am J Psychiatry 1992, 149:93\u201399.","journal-title":"Am J Psychiatry"},{"key":"160_CR8","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1176\/appi.ajp.2007.06071225","volume":"164","author":"D Warden","year":"2007","unstructured":"Warden D, Trivedi MH, Wisniewski SR, et al.: Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report. Am J Psychiatry 2007, 164:1189\u20131197.","journal-title":"Am J Psychiatry"},{"key":"160_CR9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1176\/appi.ajp.163.1.101","volume":"163","author":"M Olfson","year":"2006","unstructured":"Olfson M, Marcus S, Tedeschi M: Continuity of antidepressant treatment for adults with depression in the United States. Am J Psychiatry 2006, 163:101\u2013108.","journal-title":"Am J Psychiatry"},{"key":"160_CR10","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.biopsych.2007.03.027","volume":"62","author":"GI Papakostas","year":"2007","unstructured":"Papakostas GI, Thase ME, Fava M, et al.: Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents. Biol Psychiatry 2007, 62:1217\u20131227.","journal-title":"Biol Psychiatry"},{"key":"160_CR11","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1056\/NEJMoa052963","volume":"354","author":"AJ Rush","year":"2006","unstructured":"Rush AJ, Trivedi MH, Wisniewski SR, et al.: Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med 2006, 354:1231\u20131242.","journal-title":"N Engl J Med"},{"key":"160_CR12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","volume":"163","author":"MH Trivedi","year":"2006","unstructured":"Trivedi MH, Rush AJ, Wisniewski SR, et al.: Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006, 163:28\u201340.","journal-title":"Am J Psychiatry"},{"key":"160_CR13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/sj.mp.4001777","volume":"11","author":"TR Insel","year":"2006","unstructured":"Insel TR, Scolnick EM: Cure therapeutics and strategic prevention: raising the bar for mental health research. Mol Psychiatry 2006, 11:11\u201317.","journal-title":"Mol Psychiatry"},{"key":"160_CR14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jad.2009.01.002","volume":"117","author":"S Zisook","year":"2009","unstructured":"Zisook S, Trivedi MH, Warden D, et al.: Clinical correlates of the worsening or emergence of suicidal ideation during SSRI treatment of depression: an examination of citalopram in the STAR*D study. J Affect Disord 2009, 117:63\u201373.","journal-title":"J Affect Disord"},{"key":"160_CR15","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.neuroscience.2009.03.082","volume":"164","author":"JB Savitz","year":"2009","unstructured":"Savitz JB, Drevets WC: Imaging phenotypes of major depressive disorder: genetic correlates. Neuroscience 2009, 164:300\u2013330.","journal-title":"Neuroscience"},{"key":"160_CR16","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.psychres.2009.06.004","volume":"169","author":"AF Leuchter","year":"2009","unstructured":"\u2022\u2022 Leuchter AF, Cook IA, Marangell LB, et al.: Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in major depressive disorder: results of the BRITE-MD study. Psychiatry Res 2009, 169:124\u2013131. This study reports the effectiveness of the ATR Index for predicting treatment response in MDD and compares its effectiveness with that of other predictors, including early changes in symptoms, serum drug levels, and genetic polymorphisms.","journal-title":"Psychiatry Res"},{"key":"160_CR17","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.psychres.2009.04.004","volume":"169","author":"AF Leuchter","year":"2009","unstructured":"\u2022\u2022 Leuchter AF, Cook IA, Gilmer WS, et al.: Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder. Psychiatry Res 2009, 169:132\u2013138. This study reports that ATR predicts differential response to two antidepressants with different mechanisms of action, escitalopram and bupropion. This is the first instance in which a neurophysiologic biomarker has been shown to predict differential medication response.","journal-title":"Psychiatry Res"},{"key":"160_CR18","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nrd3115","volume":"9","author":"H Hampel","year":"2010","unstructured":"Hampel H, Frank R, Broich K, et al.: Biomarkers for Alzheimers disease: academic, industry, and regulatory perspectives. Nat Rev Drug Discov 2010, 9:560\u2013574.","journal-title":"Nat Rev Drug Discov"},{"key":"160_CR19","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1002\/hbm.20801","volume":"30","author":"PC Koolschijn","year":"2009","unstructured":"Koolschijn PC, van Haren NE, Lensvelt-Mulders GJ, et al.: Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies. Hum Brain Mapp 2009, 30:3719\u20133735.","journal-title":"Hum Brain Mapp"},{"key":"160_CR20","first-page":"91","volume":"33","author":"T Hajek","year":"2008","unstructured":"Hajek T, Kozeny J, Kopecek M, et al.: Reduced subgenual cingulate volumes in mood disorders: a meta-analysis. J Psychiatry Neurosci 2008, 33:91\u201399.","journal-title":"J Psychiatry Neurosci"},{"key":"160_CR21","first-page":"41","volume":"34","author":"M McKinnon","year":"2009","unstructured":"McKinnon M, Yucel K, Nazarov A, MacQueen G: A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder. J Psychiatry Neurosci 2009, 34:41\u201354.","journal-title":"J Psychiatry Neurosci"},{"key":"160_CR22","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.biopsych.2008.06.027","volume":"64","author":"G MacQueen","year":"2008","unstructured":"MacQueen G, Yucel K, Taylor V, et al.: Posterior hippocampal volumes are associated with remission rates in patients with major depressive disorder. Biol Psychiatry 2008, 64:880\u2013883.","journal-title":"Biol Psychiatry"},{"key":"160_CR23","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/S0006-3223(99)00296-6","volume":"47","author":"K Vakili","year":"2000","unstructured":"Vakili K, Pillay S, Lafer B, et al.: Hippocampal volume in primary unipolar major depression: a magnetic resonance imaging study. Biol Psychiatry 2000, 47:1087\u20131090.","journal-title":"Biol Psychiatry"},{"key":"160_CR24","first-page":"423","volume":"33","author":"T Frodl","year":"2008","unstructured":"Frodl T, Jager M, Smajstrlova I, et al.: Effect of hippocampal and amygdala volumes on clinical outcomes in major depression: a 3-year prospective magnetic resonance imaging study. J Psychiatry Neurosci 2008, 33:423\u2013430.","journal-title":"J Psychiatry Neurosci"},{"key":"160_CR25","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1192\/bjp.bp.107.040378","volume":"192","author":"K Kronmuller","year":"2008","unstructured":"Kronmuller K, Pantel J, Kohler S, et al.: Hippocampal volume and 2-year outcome in depression. Br J Psychiatry 2008, 192:472\u2013473.","journal-title":"Br J Psychiatry"},{"key":"160_CR26","doi-asserted-by":"crossref","first-page":"e6353","DOI":"10.1371\/journal.pone.0006353","volume":"4","author":"S Costafreda","year":"2009","unstructured":"Costafreda S, Chu C, Ashburner J, Fu C: Prognostic and diagnostic potential of the structural neuroanatomy of depression. PLoS One 2009, 4:e6353.","journal-title":"PLoS One"},{"key":"160_CR27","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1176\/appi.ajp.159.11.1929","volume":"159","author":"G Alexopoulos","year":"2002","unstructured":"Alexopoulos G, Kiosses D, Choi S, et al.: Frontal white matter microstructure and treatment response of late-life depression: a preliminary study. Am J Psychiatry 2002, 159:1929\u20131932.","journal-title":"Am J Psychiatry"},{"key":"160_CR28","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1176\/appi.ajp.2007.07050744","volume":"165","author":"G Alexopoulos","year":"2008","unstructured":"Alexopoulos G, Murphy C, Gunning-Dixon F, et al.: Microstructural white matter abnormalities and remission of geriatric depression. Am J Psychiatry 2008, 165:238\u2013244.","journal-title":"Am J Psychiatry"},{"key":"160_CR29","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/bmb\/65.1.193","volume":"65","author":"H Mayberg","year":"2003","unstructured":"Mayberg H: Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. Br Med Bull 2003, 65:193\u2013207.","journal-title":"Br Med Bull"},{"key":"160_CR30","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.biopsych.2008.06.022","volume":"65","author":"J Choi","year":"2009","unstructured":"Choi J, Jeong B, Rohan M, et al.: Preliminary evidence for white matter tract abnormalities in young adults exposed to parental verbal abuse. Biol Psychiatry 2009, 65:227\u2013234.","journal-title":"Biol Psychiatry"},{"key":"160_CR31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jad.2009.03.004","volume":"119","author":"G Alexopoulos","year":"2009","unstructured":"Alexopoulos G, Murphy C, Gunning-Dixon F, et al.: Serotonin transporter polymorphisms, microstructural white matter abnormalities and remission of geriatric depression. J Affect Disord 2009, 119:132\u2013141.","journal-title":"J Affect Disord"},{"key":"160_CR32","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1073\/pnas.98.2.676","volume":"98","author":"ME Raichle","year":"2001","unstructured":"Raichle ME, MacLeod AM, Snyder AZ, et al.: A default mode of brain function. Proc Natl Acad Sci U S A 2001, 98:676\u2013682.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"160_CR33","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.biopsych.2005.02.021","volume":"57","author":"A Anand","year":"2005","unstructured":"Anand A, Li Y, Wang Y, et al.: Activity and connectivity of brain mood regulating circuit in depression: a functional magnetic resonance study. Biol Psychiatry 2005, 57:1079\u20131088.","journal-title":"Biol Psychiatry"},{"key":"160_CR34","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1038\/sj.npp.1300725","volume":"30","author":"A Anand","year":"2005","unstructured":"Anand A, Li Y, Wang Y, et al.: Antidepressant effect on connectivity of the mood-regulating circuit: an FMRI study. Neuropsychopharmacology 2005, 30:1334\u20131344.","journal-title":"Neuropsychopharmacology"},{"key":"160_CR35","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.biopsych.2004.10.028","volume":"57","author":"S Surguladze","year":"2005","unstructured":"Surguladze S, Brammer M, Keedwell P, et al.: A differential pattern of neural response toward sad versus happy facial expressions in major depressive disorder. Biol Psychiatry 2005, 57:201\u2013209.","journal-title":"Biol Psychiatry"},{"key":"160_CR36","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/WNR.0b013e3283294159","volume":"20","author":"S Costafreda","year":"2009","unstructured":"Costafreda S, Khanna A, Mourao-Miranda J, Fu C: Neural correlates of sad faces predict clinical remission to cognitive behavioural therapy in depression. Neuroreport 2009, 20:637\u2013641.","journal-title":"Neuroreport"},{"key":"160_CR37","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.biopsych.2007.08.020","volume":"63","author":"CHY Fu","year":"2008","unstructured":"Fu CHY, Mourao-Miranda J, Costafreda S, et al.: Pattern classification of sad facial processing: toward the development of neurobiological markers in depression. Biol Psychiatry 2008, 63:656\u2013662.","journal-title":"Biol Psychiatry"},{"key":"160_CR38","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1176\/appi.ajp.160.1.64","volume":"160","author":"R Davidson","year":"2003","unstructured":"Davidson R, Irwin W, Anderle M, Kalin N: The neural substrates of affective processing in depressed patients treated with venlafaxine. Am J Psychiatry 2003, 160:64\u201375.","journal-title":"Am J Psychiatry"},{"key":"160_CR39","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/archpsyc.61.9.877","volume":"61","author":"CHY Fu","year":"2004","unstructured":"Fu CHY, Williams SC, Cleare AJ, et al.: Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Arch Gen Psychiatry 2004, 61:877\u2013889.","journal-title":"Arch Gen Psychiatry"},{"key":"160_CR40","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0006-3223(01)01263-X","volume":"50","author":"YI Sheline","year":"2001","unstructured":"Sheline YI, Barch DM, Donnelly JM, et al.: Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biol Psychiatry 2001, 50:651\u2013658.","journal-title":"Biol Psychiatry"},{"key":"160_CR41","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.biopsych.2008.04.033","volume":"64","author":"CHY Fu","year":"2008","unstructured":"Fu CHY, Williams SC, Cleare AJ, et al.: Neural responses to sad facial expressions in major depression following cognitive behavioral therapy. Biol Psychiatry 2008, 64:505\u2013512.","journal-title":"Biol Psychiatry"},{"key":"160_CR42","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jad.2008.05.022","volume":"111","author":"S Matthews","year":"2007","unstructured":"Matthews S, Strigo I, Simmons A, et al.: Decreased functional coupling of the amygdala and supragenual cingulate is related to increased depression in unmedicated individuals with current major depressive disorder. J Affect Disord 2007, 111:13\u201320.","journal-title":"J Affect Disord"},{"key":"160_CR43","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1038\/sj.npp.1301593","volume":"33","author":"C Chen","year":"2008","unstructured":"Chen C, Suckling J, Ooi C, et al.: Functional coupling of the amygdala in depressed patients treated with antidepressant medication. Neuropsychopharmacology 2008, 33:1909\u20131918.","journal-title":"Neuropsychopharmacology"},{"key":"160_CR44","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1176\/appi.neuropsych.19.3.274","volume":"19","author":"A Anand","year":"2007","unstructured":"Anand A, Li Y, Wang Y, et al.: Reciprocal effects of antidepressant treatment on activity and connectivity of the mood regulating circuit: an FMRI study. J Neuropsychiatry Clin Neurosci 2007, 19:274\u2013282.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"160_CR45","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pscychresns.2008.09.004","volume":"173","author":"MS Milak","year":"2009","unstructured":"Milak MS, Parsey RV, Lee L, et al.: Pretreatment regional brain glucose uptake in the midbrain on PET may predict remission from a major depressive episode after three months of treatment. Psychiatry Res 2009, 173:63\u201370.","journal-title":"Psychiatry Res"},{"key":"160_CR46","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/sj.mp.4002149","volume":"13","author":"M Reimold","year":"2008","unstructured":"Reimold M, Batra A, Knobel A, et al.: Anxiety is associated with reduced central serotonin transporter availability in unmedicated patients with unipolar major depression: a [11C]DASB PET study. Mol Psychiatry 2008, 13:606\u2013613, 557.","journal-title":"Mol Psychiatry"},{"key":"160_CR47","doi-asserted-by":"crossref","unstructured":"Selvaraj S, Venkatesha Murthy N, Bhagwagar Z, et al.: Diminished brain 5-HT transporter binding in major depression: a positron emission tomography study with [(11)C]DASB. Psychopharmacology (Berl) 2009 Sep 16 (Epub ahead of print).","DOI":"10.1007\/s00213-009-1660-y"},{"key":"160_CR48","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1017\/S1461145709991027","volume":"13","author":"G Laje","year":"2010","unstructured":"Laje G, Cannon DM, Allen AS, et al.: Genetic variation in HTR2A influences serotonin transporter binding potential as measured using PET and [11C]DASB. Int J Neuropsychopharmacol 2010, 13:715\u2013724.","journal-title":"Int J Neuropsychopharmacol"},{"key":"160_CR49","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1098\/rstb.2005.1649","volume":"360","author":"T Koenig","year":"2005","unstructured":"Koenig T, Studer D, Hubl D, et al.: Brain connectivity at different time-scales measured with EEG. Philos Trans R Soc Lond B Biol Sci 2005, 360:1015\u20131023.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"160_CR50","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.biopsych.2007.10.009","volume":"63","author":"GE Bruder","year":"2008","unstructured":"Bruder GE, Sedoruk JP, Stewart JW, et al.: Electroencephalographic alpha measures predict therapeutic response to a selective serotonin reuptake inhibitor antidepressant: pre- and post-treatment findings. Biol Psychiatry 2008, 63:1171\u20131177.","journal-title":"Biol Psychiatry"},{"key":"160_CR51","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0925-4927(99)00006-2","volume":"90","author":"AF Leuchter","year":"1999","unstructured":"Leuchter AF, Uijtdehaage SH, Cook IA, et al.: Relationship between brain electrical activity and cortical perfusion in normal subjects. Psychiatry Res 1999, 90:125\u2013140.","journal-title":"Psychiatry Res"},{"key":"160_CR52","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0013-4694(98)00092-3","volume":"107","author":"IA Cook","year":"1998","unstructured":"Cook IA, O\u2019Hara R, Uijtdehaage SH, et al.: Assessing the accuracy of topographic EEG mapping for determining local brain function. Electroencephalogr Clin Neurophysiol 1998, 107:408\u2013414.","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"160_CR53","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0893-133X(02)00294-4","volume":"27","author":"IA Cook","year":"2002","unstructured":"Cook IA, Leuchter AF, Morgan M, et al.: Early changes in prefrontal activity characterize clinical responders to antidepressants. Neuropsychopharmacology 2002, 27:120\u2013131.","journal-title":"Neuropsychopharmacology"},{"key":"160_CR54","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jpsychires.2004.12.002","volume":"39","author":"IA Cook","year":"2005","unstructured":"Cook IA, Leuchter AF, Morgan ML, et al.: Changes in prefrontal activity characterize clinical response in SSRI nonresponders: a pilot study. J Psychiatr Res 2005, 39:461\u2013466.","journal-title":"J Psychiatr Res"},{"key":"160_CR55","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.pscychresns.2009.04.011","volume":"174","author":"IA Cook","year":"2009","unstructured":"Cook IA, Hunter AM, Abrams M, et al.: Midline and right frontal brain function as a physiologic biomarker of remission in major depression. Psychiatry Res 2009, 174:152\u2013157.","journal-title":"Psychiatry Res"},{"key":"160_CR56","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jpsychires.2006.06.005","volume":"41","author":"M Bares","year":"2007","unstructured":"Bares M, Brunovsky M, Kopecek M, et al.: Changes in QEEG prefrontal cordance as a predictor of response to antidepressants in patients with treatment resistant depressive disorder: a pilot study. J Psychiatr Res 2007, 41:319\u2013325.","journal-title":"J Psychiatr Res"},{"key":"160_CR57","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.eurpsy.2008.03.001","volume":"23","author":"M Bares","year":"2008","unstructured":"Bares M, Brunovsky M, Kopecek M, et al.: Early reduction in prefrontal theta QEEG cordance value predicts response to venlafaxine treatment in patients with resistant depressive disorder. Eur Psychiatry 2008, 23:350\u2013355.","journal-title":"Eur Psychiatry"},{"key":"160_CR58","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.euroneuro.2010.03.007","volume":"20","author":"M Bares","year":"2010","unstructured":"Bares M, Brunovsky M, Novak T, et al.: The change of prefrontal QEEG theta cordance as a predictor of response to bupropion treatment in patients who had failed to respond to previous antidepressant treatments. Eur Neuropsychopharmacol 2010, 20:459\u2013466.","journal-title":"Eur Neuropsychopharmacol"},{"key":"160_CR59","first-page":"524","volume":"28","author":"M Kopecek","year":"2007","unstructured":"Kopecek M, Sos P, Brunovsky M, et al.: Can prefrontal theta cordance differentiate between depression recovery and dissimulation? Neuro Endocrinol Lett 2007, 28:524\u2013526.","journal-title":"Neuro Endocrinol Lett"},{"key":"160_CR60","first-page":"295","volume":"29","author":"M Kopecek","year":"2008","unstructured":"Kopecek M, Tislerova B, Sos P, et al.: QEEG changes during switch from depression to hypomania\/mania: a case report. Neuro Endocrinol Lett 2008, 29:295\u2013302.","journal-title":"Neuro Endocrinol Lett"},{"key":"160_CR61","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1176\/appi.ajp.158.3.405","volume":"158","author":"D Pizzagalli","year":"2001","unstructured":"Pizzagalli D, Pascual-Marqui RD, Nitschke JB, et al.: Anterior cingulate activity as a predictor of degree of treatment response in major depression: evidence from brain electrical tomography analysis. Am J Psychiatry 2001, 158:405\u2013415.","journal-title":"Am J Psychiatry"},{"key":"160_CR62","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0304-3940(99)00679-5","volume":"274","author":"H Asada","year":"1999","unstructured":"Asada H, Fukuda Y, Tsunoda S, et al.: Frontal midline theta rhythms reflect alternative activation of prefrontal cortex and anterior cingulate cortex in humans. Neurosci Lett 1999, 274:29\u201332.","journal-title":"Neurosci Lett"},{"key":"160_CR63","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.euroneuro.2009.06.001","volume":"19","author":"DV Iosifescu","year":"2009","unstructured":"Iosifescu DV, Greenwald S, Devlin P, et al.: Frontal EEG predictors of treatment outcome in major depressive disorder. Eur Neuropsychopharmacol 2009, 19:772\u2013777.","journal-title":"Eur Neuropsychopharmacol"},{"key":"160_CR64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FPC.0b013e3283163ecd","volume":"19","author":"EJ Peters","year":"2009","unstructured":"Peters EJ, Slager SL, Jenkins GD, et al.: Resequencing of serotonin-related genes and association of tagging SNPs to citalopram response. Pharmacogenet Genomics 2009, 19:1\u201310.","journal-title":"Pharmacogenet Genomics"},{"key":"160_CR65","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.biopsych.2007.09.016","volume":"62","author":"G Laje","year":"2007","unstructured":"Laje G, McMahon FJ: The pharmacogenetics of major depression: past, present, and future. Biol Psychiatry 2007, 62:1205\u20131207.","journal-title":"Biol Psychiatry"},{"key":"160_CR66","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.4088\/JCP.09ac05519","volume":"70","author":"HA Garriock","year":"2009","unstructured":"Garriock HA, Hamilton SP: Genetic studies of drug response and side effects in the STAR*D study, part 1. J Clin Psychiatry 2009, 70:1186\u20131187.","journal-title":"J Clin Psychiatry"},{"key":"160_CR67","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1176\/ps.2009.60.11.1446","volume":"60","author":"G Laje","year":"2009","unstructured":"Laje G, Perlis RH, Rush AJ, McMahon FJ: Pharmacogenetics studies in STAR*D: strengths, limitations, and results. Psychiatr Serv 2009, 60:1446\u20131457.","journal-title":"Psychiatr Serv"},{"key":"160_CR68","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.biopsych.2006.07.017","volume":"61","author":"JB Kraft","year":"2007","unstructured":"Kraft JB, Peters EJ, Slager SL, et al.: Analysis of association between the serotonin transporter and antidepressant response in a large clinical sample. Biol Psychiatry 2007, 61:734\u2013742.","journal-title":"Biol Psychiatry"},{"key":"160_CR69","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1086\/503820","volume":"78","author":"FJ McMahon","year":"2006","unstructured":"McMahon FJ, Buervenich S, Charney D, et al.: Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. Am J Hum Genet 2006, 78:804\u2013814.","journal-title":"Am J Hum Genet"},{"key":"160_CR70","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/ajmg.b.30816","volume":"150B","author":"DA Mrazek","year":"2009","unstructured":"Mrazek DA, Rush AJ, Biernacka JM, et al.: SLC6A4 variation and citalopram response. Am J Med Genet B Neuropsychiatr Genet 2009, 150B:341\u2013351.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"160_CR71","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1001\/archgenpsychiatry.2009.95","volume":"66","author":"M Ising","year":"2009","unstructured":"Ising M, Lucae S, Binder EB, et al.: A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression. Arch Gen Psychiatry 2009, 66:966\u2013975.","journal-title":"Arch Gen Psychiatry"},{"key":"160_CR72","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.biopsych.2009.08.029","volume":"67","author":"HA Garriock","year":"2010","unstructured":"\u2022\u2022 Garriock HA, Kraft JB, Shyn SI, et al.: A genomewide association study of citalopram response in major depressive disorder. Biol Psychiatry 2010, 67:133\u2013138. This article reports the results of the first GWAS in the STAR*D sample aimed at identifying common alleles that influence response to antidepressant treatment. It is a particularly comprehensive examination of possible genomic predictors of antidepressant treatment.","journal-title":"Biol Psychiatry"},{"key":"160_CR73","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1176\/appi.ajp.2009.09070932","volume":"167","author":"R Uher","year":"2010","unstructured":"Uher R, Perroud N, Ng MY, et al.: Genome-wide pharmacogenetics of antidepressant response in the GENDEP project.. Am J Psychiatry 2010, 167:555\u2013564.","journal-title":"Am J Psychiatry"},{"key":"160_CR74","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1176\/appi.ajp.2009.08121760","volume":"166","author":"E Sibille","year":"2009","unstructured":"Sibille E, Wang Y, Joeyen-Waldorf J, et al.: A molecular signature of depression in the amygdala. Am J Psychiatry 2009, 166:1011\u20131024.","journal-title":"Am J Psychiatry"},{"key":"160_CR75","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1080\/07853890802082088","volume":"40","author":"J Iga","year":"2008","unstructured":"Iga J, Ueno S, Ohmori T: Molecular assessment of depression from mRNAs in the peripheral leukocytes. Ann Intern Med 2008, 40:336\u2013342.","journal-title":"Ann Intern Med"},{"key":"160_CR76","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/mp.2009.65","volume":"15","author":"RH Segman","year":"2009","unstructured":"Segman RH, Goltser-Dubner T, Weiner I, et al.: Blood mononuclear cell gene expression signature of postpartum depression. Mol Psychiatry 2009, 15:93\u2013100.","journal-title":"Mol Psychiatry"},{"key":"160_CR77","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1093\/hmg\/ddp397","volume":"18","author":"AJ Jasinska","year":"2009","unstructured":"Jasinska AJ, Service S, Choi OW, et al.: Identification of brain transcriptional variation reproduced in peripheral blood: an approach for mapping brain expression traits. Hum Mol Genet 2009, 18:4415\u20134427.","journal-title":"Hum Mol Genet"},{"key":"160_CR78","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.pnpbp.2006.12.014","volume":"31","author":"J Iga","year":"2007","unstructured":"Iga J, Ueno S, Yamauchi K, et al.: Altered HDAC5 and CREB mRNA expressions in the peripheral leukocytes of major depression. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:628\u2013632.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"160_CR79","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jpsychires.2009.08.015","volume":"44","author":"T Hobara","year":"2010","unstructured":"Hobara T, Uchida S, Otsuki K, et al.: Altered gene expression of histone deacetylases in mood disorder patients. J Psychiatr Res 2010, 44:263\u2013270.","journal-title":"J Psychiatr Res"},{"key":"160_CR80","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrg2537","volume":"10","author":"W Cookson","year":"2009","unstructured":"Cookson W, Liang L, Abecasis G, et al.: Mapping complex disease traits with global gene expression. Nat Rev Genet 2009, 10:184\u2013194.","journal-title":"Nat Rev Genet"},{"key":"160_CR81","first-page":"297","volume":"27","author":"TJ Raedler","year":"2006","unstructured":"Raedler TJ, Wiedemann K: CSF-studies in neuropsychiatric disorders. Neuro Endocrinol Lett 2006, 27:297\u2013305.","journal-title":"Neuro Endocrinol Lett"},{"key":"160_CR82","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1002\/pmic.200500069","volume":"6","author":"CL Beasley","year":"2006","unstructured":"Beasley CL, Pennington K, Behan A, et al.: Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: evidence for disease-associated changes. Proteomics 2006, 6:3414\u20133425.","journal-title":"Proteomics"},{"key":"160_CR83","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/npp.2008.174","volume":"34","author":"R Kaddurah-Daouk","year":"2009","unstructured":"Kaddurah-Daouk R, Krishnan KR: Metabolomics: a global biochemical approach to the study of central nervous system diseases. Neuropsychopharmacology 2009, 34:173\u2013186.","journal-title":"Neuropsychopharmacology"},{"key":"160_CR84","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/gps.1690","volume":"22","author":"LA Paige","year":"2007","unstructured":"Paige LA, Mitchell MW, Krishnan KR, et al.: A preliminary metabolomic analysis of older adults with and without depression. Int J Geriatr Psychiatry 2007, 22:418\u2013423.","journal-title":"Int J Geriatr Psychiatry"},{"key":"160_CR85","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.biopsych.2006.02.013","volume":"59","author":"RS Duman","year":"2006","unstructured":"Duman RS, Monteggia LM: A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006, 59:1116\u20131127.","journal-title":"Biol Psychiatry"},{"key":"160_CR86","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1055\/s-0029-1224162","volume":"42","author":"A Sartorius","year":"2009","unstructured":"Sartorius A, Hellweg R, Litzke J, et al.: Correlations and discrepancies between serum and brain tissue levels of neurotrophins after electroconvulsive treatment in rats. Pharmacopsychiatry 2009, 42:270\u2013276.","journal-title":"Pharmacopsychiatry"},{"key":"160_CR87","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1017\/S1461145708009309","volume":"11","author":"AR Brunoni","year":"2008","unstructured":"Brunoni AR, Lopes M, Fregni F: A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int J Neuropsychopharmacol 2008, 11:1169\u20131180.","journal-title":"Int J Neuropsychopharmacol"},{"key":"160_CR88","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.biopsych.2008.05.005","volume":"64","author":"S Sen","year":"2008","unstructured":"Sen S, Duman R, Sanacora G: Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry 2008, 64:527\u2013532.","journal-title":"Biol Psychiatry"},{"key":"160_CR89","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jpsychires.2008.03.014","volume":"43","author":"F Matrisciano","year":"2009","unstructured":"Matrisciano F, Bonaccorso S, Ricciardi A, et al.: Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine. J Psychiatry Res 2009, 43:247\u2013254.","journal-title":"J Psychiatry Res"}],"container-title":["Current Psychiatry Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s11920-010-0160-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T04:09:35Z","timestamp":1636690175000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11920-010-0160-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10,21]]},"references-count":89,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["160"],"URL":"https:\/\/doi.org\/10.1007\/s11920-010-0160-4","relation":{},"ISSN":["1523-3812","1535-1645"],"issn-type":[{"value":"1523-3812","type":"print"},{"value":"1535-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,21]]}}}